Loading stock data…
TherapeuticsMD (TXMD)
$2.23+0.12 (+5.69%)
Market OpenUpdated 3:03 PM EDT
TherapeuticsMD, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
TherapeuticsMD, Inc. in the Healthcare sector is trading at $2.23 with a market capitalization of $26M. The stock is currently 24% below its 52-week high of $2.95, remaining 20.5% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $724,000↓ | $893,000↑ | $784,000↓ | $952,000↑ | $393,000 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$723,000↑ | -$1.50M↓ | -$830,000↓ | -$695,000↑ | -$1.19M |
| Net Income | $95,000↑ | -$619,000↓ | $152,000↓ | $551,000↑ | -$653,000 |
Peer Comparison
JNJUNHPFE
Fundamentals
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. The company provides IMVEXXY, for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; B...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$26.10M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
0.66%
Volume
Today's trading volume
39,262
Recent News
TherapeuticsMD: Q3 Earnings Snapshot
BOCA RATON, Fla. AP) — TherapeuticsMD Inc. TXMD) on Wednesday reported earnings of $152,000 in its third quarter.
TherapeuticsMD: Q2 Earnings Snapshot
BOCA RATON, Fla. AP) — TherapeuticsMD Inc. TXMD) on Tuesday reported net income of $551,000 in its second quarter.